Evolving therapeutic goals in ulcerative colitis: towards disease clearance
- PMID: 31520081
- DOI: 10.1038/s41575-019-0211-1
Evolving therapeutic goals in ulcerative colitis: towards disease clearance
References
-
- Ungaro, R. et al. A Treat-to-target update in ulcerative colitis: a systematic review. Am. J. Gastroenterol. 114, 874–883 (2019). - DOI
-
- Peyrin–Biroulet, L., Bressenot, A. & Kampman, W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin. Gastroenterol. Hepatol. 12, 929–934 (2014). - DOI
-
- Strober, B. E. et al. Clinical goals and barriers to effective psoriasis care. Dermatol. Ther. 9, 5–18 (2019). - DOI
-
- Boni, E. Elewski et al. Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75–89 response: results from two phase 3 studies of secukinumab. J. Dermatolog Treat. 28, 492–499 (2017). - DOI
-
- Shelton, S. K. et al. Ixekizumab: a review of its use for the management of moderate to severe plaque psoriasis. Ann. Pharmacother. 53, 276–284 (2019). - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
